dc.contributor.advisor | Sabrina, Sharmin | |
dc.contributor.author | Nashrah, Zannatul | |
dc.date.accessioned | 2023-12-21T06:10:09Z | |
dc.date.available | 2023-12-21T06:10:09Z | |
dc.date.copyright | 2023 | |
dc.date.issued | 2023-02 | |
dc.identifier.other | ID 19146072 | |
dc.identifier.uri | http://hdl.handle.net/10361/22021 | |
dc.description | This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023. | en_US |
dc.description | Cataloged from PDF version of thesis. | |
dc.description | Includes bibliographical references (pages 38-45). | |
dc.description.abstract | Cell penetrating peptides have been identified as a viable tool for therapeutic use in the era of biomedicines and specialized carrier systems. Similar to other therapeutic peptides, peptide stability- the bottleneck for this class of biodegradable molecules will play a critical role in the effective in vivo deployment of CPPs. Peptide-based administration could improve drug uptake in tumor cells, increasing the effectiveness of either conventional small-molecule medications or oligonucleotide-based treatments. To facilitate the achievement of therapeutic interventions, a thorough understanding of the cancer applications of cell penetrating peptides as delivery systems is stressed; including various aspects of drug loading, cargoes, and delivery are discussed along with techniques for targeted delivery, activatable cell-penetrating peptides, and transducible agents coupled to cell-penetrating peptides. Limitations and possible solutions invented are also mentioned. | en_US |
dc.description.statementofresponsibility | Zannatul Nashrah | |
dc.format.extent | 45 pages | |
dc.language.iso | en | en_US |
dc.publisher | Brac University | en_US |
dc.rights | Brac University theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. | |
dc.subject | Cancer | en_US |
dc.subject | Cancer penetrating peptides | en_US |
dc.subject | Drug delivery | en_US |
dc.subject | Oligonucleotides | en_US |
dc.subject | siRNA | en_US |
dc.subject | Therapies | en_US |
dc.subject | CPP | en_US |
dc.subject.lcsh | Cancer--Treatment | |
dc.subject.lcsh | Multidrug delivery. | |
dc.title | The impact of cell penetrating peptides in prospective cancer therapy: a review | en_US |
dc.type | Thesis | en_US |
dc.contributor.department | School of Pharmacy, Brac University | |
dc.description.degree | B. Pharmacy | |